Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-16-014103
Filing Date
2016-06-30
Accepted
2016-06-30 16:54:36
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B4 a2229083z424b4.htm 424B4 2332611
2 G778263.JPG g778263.jpg GRAPHIC 31094
3 G247059.JPG g247059.jpg GRAPHIC 75343
4 G467346.JPG g467346.jpg GRAPHIC 78093
5 G482247.JPG g482247.jpg GRAPHIC 72520
6 G277089.JPG g277089.jpg GRAPHIC 33654
7 G388.JPG g388.jpg GRAPHIC 47285
8 G814920.JPG g814920.jpg GRAPHIC 33866
9 G829366.JPG g829366.jpg GRAPHIC 53628
10 G134515.JPG g134515.jpg GRAPHIC 48065
11 G657957.JPG g657957.jpg GRAPHIC 77975
12 G332127.JPG g332127.jpg GRAPHIC 74779
13 G79917.JPG g79917.jpg GRAPHIC 51658
14 G909941.JPG g909941.jpg GRAPHIC 44636
15 G983587.JPG g983587.jpg GRAPHIC 54230
16 G57754.JPG g57754.jpg GRAPHIC 46553
17 G721486.JPG g721486.jpg GRAPHIC 67098
  Complete submission text file 0001047469-16-014103.txt   3562391
Mailing Address 480 ARSENAL STREET SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 130 WATERTOWN MA 02472 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-211818 | Film No.: 161743723
SIC: 2834 Pharmaceutical Preparations